Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000002

Options or other derivatives

  • Chief Financial Officer acquired 241,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Piscitelli Dominic Chief Financial Officer 2026-01-02 Grant or award · Stock Option (right to buy) +206,500 206,500 D
Piscitelli Dominic Chief Financial Officer 2026-01-02 Grant or award · Restricted Stock Unit +34,500 34,500 D
Loading xslF345X05/form4-01062026_090131.xml…